BEHLING JIM,DOUGAN CHRISTINE HENDERSON,FIGINI ATTILIA,WATT STEPHEN WILLIAM,ANDERSON KEITH,MANINI PETER
申请号：
NZ59570610
公开号：
NZ595706A
申请日:
2010.04.01
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
595706 Provided are crystalline forms of L-ornithine phenyl acetate, as depicted in structure (V), and methods of making the same. The crystalline form may, in some embodiments, be of Form I, II, III or V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
